Alfredo Torres, PhD, MS

Associate Dean, Faculty Affairs and Professional Development, and Chief Diversity Officer

  • 5752 Citations
  • 38 h-Index
1995 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Alfredo Torres is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Escherichia coli O157 Medicine & Life Sciences
Enterohemorrhagic Escherichia coli Medicine & Life Sciences
Melioidosis Medicine & Life Sciences
Burkholderia mallei Medicine & Life Sciences
Burkholderia pseudomallei Medicine & Life Sciences
Escherichia coli Medicine & Life Sciences
Glanders Medicine & Life Sciences
Enteropathogenic Escherichia coli Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2009 2021

Research Output 1995 2019

4 Citations (Scopus)

Burkholderia pseudomallei ΔtonB Δhcp1 Live Attenuated Vaccine Strain Elicits Full Protective Immunity against Aerosolized Melioidosis Infection

Khakhum, N., Bharaj, P., Myers, J. N., Tapia, D., Kilgore, P. B., Ross, B. N., Walker, D., Endsley, J. & Torres, A., Jan 2 2019, In : mSphere. 4, 1

Research output: Contribution to journalArticle

Melioidosis
Burkholderia pseudomallei
Attenuated Vaccines
Immunity
Infection

Comparative genomics of a subset of Adherent/Invasive Escherichia coli strains isolated from individuals without inflammatory bowel disease

Barrios-Villa, E., Martínez de la Peña, C. F., Lozano-Zaraín, P., Cevallos, M. A., Torres, C., Torres, A. G. & Rocha-Gracia, R. D. C., Jan 1 2019, (Accepted/In press) In : Genomics.

Research output: Contribution to journalArticle

Genomics
Inflammatory Bowel Diseases
Escherichia coli
Single Nucleotide Polymorphism
Genomic Islands

Development of a gold nanoparticle vaccine against enterohemorrhagic escherichia coli o157:H7

Sanchez-Villamil, J. I., Tapia, D. & Torres, A. G., Jan 1 2019, In : mBio. 10, 4, e01869-19.

Research output: Contribution to journalArticle

Open Access
Enterohemorrhagic Escherichia coli
Escherichia coli O157
Gold
Nanoparticles
Vaccines

Emerging role of biologics for the treatment of melioidosis and glanders

Tapia, D., Sanchez-Villamil, J. I. & Torres, A. G., Jan 1 2019, (Accepted/In press) In : Expert Opinion on Biological Therapy.

Research output: Contribution to journalReview article

Glanders
Melioidosis
Biological Products
Burkholderia mallei
Burkholderia pseudomallei

Evaluating the role of Burkholderia pseudomallei K96243 toxins BPSS0390, BPSS0395, and BPSS1584 in persistent infection

Ross, B. N., Micheva-Viteva, S., Hong-Geller, E. & Torres, A., Jan 1 2019, (Accepted/In press) In : Cellular Microbiology. e13096.

Research output: Contribution to journalArticle

Burkholderia pseudomallei
Anti-Bacterial Agents
Melioidosis
Infection
Levofloxacin